title: NLRP3, a potential therapeutic target for type 2 diabetes?
authors.affiliation: Shanghai Pudong Institute for Health Development, 818 Laiyang Road, Pudong, Shanghai, People's Republic of China.
authors.forename: Shan-Shan
authors.initials: SS
authors.lastname: Liu
authors.forename: Ye
authors.initials: Y
authors.lastname: Ding
authors.forename: Ji-Quan
authors.initials: JQ
authors.lastname: Lou
mesh_terms: D000818:Animals; D003924:Diabetes Mellitus, Type 2 / Q000150:complications*; D058065:Diabetic Cardiomyopathies / Q000188:drug therapy*; D005464:Fluorobenzenes / Q000494:pharmacology*; D011743:Pyrimidines / Q000494:pharmacology*; D018160:Receptors, Cytoplasmic and Nuclear / Q000235:genetics*; D013449:Sulfonamides / Q000494:pharmacology*
chemical_list: D005464:Fluorobenzenes; D011743:Pyrimidines; D018160:Receptors, Cytoplasmic and Nuclear; D013449:Sulfonamides